The Role of a Conserved Arg-Asp Pair in the Structure and Function of Tetanus Neurotoxin.
Abstract
Tetanus, a severe and life-threatening illness caused by , produces symptoms such as muscle spasms, muscle stiffness and seizures caused by the production of tetanus neurotoxin (TeNT). TeNT causes spastic paralysis through the inhibition of neurotransmission in spinal inhibitory interneurons. This is achieved, in part, through pH-triggered membrane insertion of the translocation (HCT) domain, which delivers the catalytic light-chain (LC) domain to the cytosol. While the function of HCT is well defined, the mechanism by which it accomplishes this task is largely unknown. Based on the crystal structure of tetanus neurotoxin, we identified potential polar interactions between arginine 711, tryptophan 715 and aspartate 821 that appear to be evolutionarily conserved across the clostridial neurotoxin family. We show that the disruption of the Asp-Arg pair in a beltless HCT variant (bHCT) results in changes in thermal stability without significant alterations to the overall secondary structure. ANS (1-anilino-8-napthalene sulfonate) binding studies, in conjunction with liposome permeabilization assays, demonstrate that mutations at R711 or D821 trigger interactions with the membrane at higher pH values compared to wildtype bHCT. Interestingly, we show that the introduction of the D821N mutation into LHT (LC-HCT only), but not the holotoxin, resulted in the increased cleavage of VAMP 2 in cortical neurons relative to the wildtype protein. This suggests that, as observed for botulinum toxin A, the receptor-binding domain is not necessary for LC translocation but rather helps determine the pH threshold of membrane insertion. The mutation of W715 did not result in detectable changes in the activity of either bHCT or the holotoxin, suggesting that it plays only a minor role in stabilizing the structure of the toxin. We conclude that the protonation of D821 at low pH disrupts interactions with R711 and W715, helping to drive the conformational refolding of HCT needed for membrane insertion and the subsequent translocation of the LC.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | botulinum toxin
|
보툴리눔독소 주사 | dict | 1 | |
| 해부 | membrane
|
scispacy | 1 | ||
| 해부 | cortical neurons
|
scispacy | 1 | ||
| 해부 | muscle
|
scispacy | 1 | ||
| 해부 | spinal
|
scispacy | 1 | ||
| 해부 | pH-triggered membrane
|
scispacy | 1 | ||
| 해부 | cytosol
|
scispacy | 1 | ||
| 합병증 | interneurons
|
scispacy | 1 | ||
| 약물 | liposome
|
scispacy | 1 | ||
| 약물 | holotoxin
|
scispacy | 1 | ||
| 약물 | arginine
|
C0003765
arginine
|
scispacy | 1 | |
| 약물 | tryptophan
|
C0041249
tryptophan
|
scispacy | 1 | |
| 약물 | aspartate
|
C0085845
aspartate
|
scispacy | 1 | |
| 질환 | Tetanus
|
C0039614
Tetanus
|
scispacy | 1 | |
| 질환 | muscle spasms
|
C0037763
Spasm
|
scispacy | 1 | |
| 질환 | muscle stiffness
|
C0221170
Muscular stiffness
|
scispacy | 1 | |
| 질환 | seizures
|
C0036572
Seizures
|
scispacy | 1 | |
| 질환 | spastic paralysis
|
C0085621
Spastic paralysis
|
scispacy | 1 | |
| 질환 | Tetanus Neurotoxin
|
scispacy | 1 | ||
| 질환 | HCT
|
scispacy | 1 | ||
| 기타 | clostridial neurotoxin
|
scispacy | 1 | ||
| 기타 | Asp-Arg
|
scispacy | 1 | ||
| 기타 | LC-HCT
|
scispacy | 1 | ||
| 기타 | VAMP 2
|
scispacy | 1 | ||
| 기타 | Tetanus
|
scispacy | 1 | ||
| 기타 | neurotoxin
|
scispacy | 1 | ||
| 기타 | TeNT
→ tetanus neurotoxin
|
scispacy | 1 | ||
| 기타 | light-chain
|
scispacy | 1 | ||
| 기타 | arginine 711, tryptophan 715
|
scispacy | 1 |
MeSH Terms
Tetanus Toxin; Arginine; Aspartic Acid; Metalloendopeptidases; Humans; Mutation
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Local therapeutic strategies for neurocutaneous dysesthesia: from capsaicin to cannabinoids.
- Comparative efficacy of intralesional therapies for keloid scars: a network meta-analysis.
- Adverse neurological events following botulinum toxin type A: A case series of post-injection seizures and paralysis.
- Decreased utilization of component separation techniques over time in complex abdominal wall reconstruction following introduction of preoperative botulinum toxin A.
- Current Perspectives on Pectoralis Minor Syndrome: A Narrative Review.